Doctors from across the city have raised serious concerns regarding the World Health Organisation's (WHO) recent findings of the Solidarity Trial, which shows the wonder drug Remdesivir as non-effective in the treatment of COVID-19. Health experts are now worried about its side-effects as lakhs of patients have already been administered the drug as a line of treatment for the infectious disease. mid-day had in its article dated July 1 raised serious concerns about such wonder drugs.

Speaking to mid-day, Dr Wiqar Shaikh, senior allergy and asthma specialist said, "In the recent statement, WHO concluded that Remdesivir, HCQ, Lopinavir/Ritonavir and Interferon have no effect on patients with COVID-19. The Solidarity Trial was conducted for 28 days and involved 11,266 adult COVID-19 patients in 405 hospitals across 30 countries. The result of the trial reveals that none of these drugs reduced hospital stay and mortality rate among patients. Moreover, Remdesivir had failed in the trial conducted for Ebola virus, for which it was primarily discovered."